Show
Sort by
-
- Journal Article
- A1
- open access
Antibodies gone bad : the molecular mechanism of light chain amyloidosis
-
- Journal Article
- A1
- open access
Multimeric ACE2-IgM fusions as broadly active antivirals that potently neutralize SARS-CoV-2 variants
-
- Journal Article
- A1
- open access
Mechanistic principles of an ultra-long bovine CDR reveal strategies for antibody design
-
- Journal Article
- A1
- open access
Picomolar inhibition of SARS-CoV-2 variants of concern by an engineered ACE2-IgG4-Fc fusion protein